var data={"title":"Stasis dermatitis","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Stasis dermatitis</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/contributors\" class=\"contributor contributor_credentials\">Anthony F Fransway, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/contributors\" class=\"contributor contributor_credentials\">Joseph Fowler, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/contributors\" class=\"contributor contributor_credentials\">Rosamaria Corona, MD, DSc</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Dec 08, 2016.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H358752\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Stasis dermatitis, or stasis eczema, is a common inflammatory dermatosis of the lower extremities occurring in patients with chronic venous insufficiency, often in association with varicose veins, dependent chronic edema, hyperpigmentation, lipodermatosclerosis, and ulcerations. Stasis dermatitis may rarely involve the upper limbs in patients with artificial arteriovenous (AV) fistulas for hemodialysis, or congenital AV malformations [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/1\" class=\"abstract_t\">1</a>]. </p><p>This topic will discuss the pathogenesis, clinical presentation, complications, and treatment of stasis dermatitis. The pathophysiology, clinical and diagnostic evaluation, and treatment of lower extremity chronic venous disease are discussed separately.</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=pathophysiology-of-chronic-venous-disease\" class=\"medical medical_review\">&quot;Pathophysiology of chronic venous disease&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=diagnostic-evaluation-of-lower-extremity-chronic-venous-insufficiency\" class=\"medical medical_review\">&quot;Diagnostic evaluation of lower extremity chronic venous insufficiency&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=post-thrombotic-postphlebitic-syndrome\" class=\"medical medical_review\">&quot;Post-thrombotic (postphlebitic) syndrome&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=medical-management-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">&quot;Medical management of lower extremity chronic venous disease&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H214055\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin changes related to chronic venous insufficiency, including edema, hyperpigmentation, eczema, fibrosis, atrophy, and ulceration, are reported in 1 to 20 percent of women and in 1 to 17 percent of men [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/2\" class=\"abstract_t\">2</a>]. In one study, stasis dermatitis was reported in 6.2 percent of patients over the age of 65 [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/3\" class=\"abstract_t\">3</a>]. Established risk factors for varicose veins and chronic venous insufficiency include age, family history of venous disease, female sex, standing occupation, obesity, and history of deep vein thrombosis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/2,4\" class=\"abstract_t\">2,4</a>]. Heart failure and hypertension are aggravating factors. </p><p>The epidemiology of chronic venous insufficiency is discussed separately. (See <a href=\"topic.htm?path=overview-and-management-of-lower-extremity-chronic-venous-disease#H2\" class=\"medical medical_review\">&quot;Overview and management of lower extremity chronic venous disease&quot;, section on 'Epidemiology'</a>.)</p><p class=\"headingAnchor\" id=\"H26659689\"><span class=\"h1\">PATHOPHYSIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The final common pathway that leads to chronic venous insufficiency is the development of venous hypertension [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/5\" class=\"abstract_t\">5</a>]. In most cases, venous hypertension results from dysfunction of the venous valves, obstruction to the venous flow, or failure of the &quot;venous pump&quot; [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/6\" class=\"abstract_t\">6</a>]. If the valves of deep or perforator veins are incompetent, the increased pressure generated during standing or calf muscle contraction causes blood to reflux into the superficial venous system, converting it into a high-pressure system. (See <a href=\"topic.htm?path=pathophysiology-of-chronic-venous-disease#H4\" class=\"medical medical_review\">&quot;Pathophysiology of chronic venous disease&quot;, section on 'Genesis and consequences of chronic venous hypertension'</a>.)</p><p>In some patients, chronic edema of the lower extremities induced by drugs (<a href=\"image.htm?imageKey=DERM%2F98177\" class=\"graphic graphic_table graphicRef98177 \">table 1</a>) may be a contributor factor in the pathogenesis of stasis dermatitis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/7\" class=\"abstract_t\">7</a>].</p><p class=\"headingAnchor\" id=\"H311755\"><span class=\"h1\">PATHOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hyperkeratosis, parakeratosis, acanthosis, and mild spongiosis are the epidermal changes usually seen in uncomplicated stasis dermatitis. Spongiosis may be prominent in cases with a superimposed contact dermatitis. Dermal changes include proliferation of small blood vessels in the papillary dermis, variable dermal fibrosis, perivascular lymphocytic infiltration, extravasated erythrocytes, and hemosiderin-laden macrophages [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/8\" class=\"abstract_t\">8</a>]. A positive iron stain and the evaluation of the iron deposition pattern may be helpful to confirm the diagnosis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/9\" class=\"abstract_t\">9</a>]. &#160; </p><p>Signs of venous hypertension also may be seen in the dermis, including dilated capillaries with fibrin cuffs, hemosiderin deposits, and hyperplastic venules. Morphometric and ultrastructural findings include increased mast cell number, thickening of basal lamina of capillaries, and presence of transforming growth factor-beta 1 (TGF-beta 1) [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/10\" class=\"abstract_t\">10</a>]. Septal involvement of the subcutaneous fat, fat necrosis, microcyst formation, lipomembranous changes, elastosis, and calcification of adipocytes are typical features of lipodermatosclerosis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/11,12\" class=\"abstract_t\">11,12</a>]. </p><p class=\"headingAnchor\" id=\"H310245\"><span class=\"h1\">CLINICAL PRESENTATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Stasis dermatitis is a late manifestation of chronic venous disease (stage C4 of the Clinical Etiological Anatomical Pathological [CEAP] classification (<a href=\"image.htm?imageKey=SURG%2F52388\" class=\"graphic graphic_table graphicRef52388 \">table 2</a>)) [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/13\" class=\"abstract_t\">13</a>]. (See <a href=\"topic.htm?path=classification-of-lower-extremity-chronic-venous-disorders#H6\" class=\"medical medical_review\">&quot;Classification of lower extremity chronic venous disorders&quot;, section on 'CEAP classification'</a>.)</p><p>Stasis dermatitis typically presents with erythematous, scaling, and eczematous patches or plaques on chronically edematous legs. The medial ankle is most frequently and severely involved, although the skin changes may extend up to the knee and down to the foot (<a href=\"image.htm?imageKey=DERM%2F70596%7EDERM%2F50640%7EDERM%2F78163%7EDERM%2F64878\" class=\"graphic graphic_picture graphicRef70596 graphicRef50640 graphicRef78163 graphicRef64878 \">picture 1A-D</a>). Pruritus is variable but, when present, results in lichenification from chronic scratching or rubbing. Acute forms may present with severely inflamed weeping plaques, vesiculation, and crusting. Impetiginized crusts <span class=\"nowrap\">and/or</span> pustules due to bacterial or candidal superinfection may also be seen. Chronic forms are characterized by hyperpigmentation, due to dermal hemosiderin deposition, scaling, and potential development of lipodermatosclerosis.</p><p>Lipodermatosclerosis is a chronic form of panniculitis resulting from chronic inflammation, fat degeneration, and fibrosis. In the acute phase, lipodermatosclerosis presents with a painful erythema of the medial perimalleolar region that mimics cellulitis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/14\" class=\"abstract_t\">14</a>]. However, in contrast with cellulitis, lipodermatosclerosis develops slowly, over weeks to months, and usually involves both legs. The chronic phase is characterized by hyperpigmented and indurated skin that constricts the ankle region, giving the legs an appearance of an inverted champagne bottle (<a href=\"image.htm?imageKey=DERM%2F65447\" class=\"graphic graphic_picture graphicRef65447 \">picture 2</a>). </p><p>Patients with stasis dermatitis may present with other signs of chronic venous insufficiency and related comorbidities, including: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Varicosities </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Secondary lymphedema</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Atrophie blanche (stellate, porcelain-white scarring areas resulting from microthromboses) (<a href=\"image.htm?imageKey=DERM%2F87627\" class=\"graphic graphic_picture graphicRef87627 \">picture 3</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Secondary cellulitis</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Ulceration </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=clinical-manifestations-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">&quot;Clinical manifestations of lower extremity chronic venous disease&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H310424\"><span class=\"h1\">COMPLICATIONS</span></p><p class=\"headingAnchor\" id=\"H107526\"><span class=\"h2\">Contact sensitization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with stasis dermatitis and venous leg ulcers have a higher frequency of contact allergy than the general population. (See <a href=\"topic.htm?path=basic-mechanisms-and-pathophysiology-of-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Basic mechanisms and pathophysiology of allergic contact dermatitis&quot;</a>.)</p><p>The prevalence of contact sensitization to at least one substance among patch tested patients with stasis dermatitis or leg ulcers ranged from 46 to 82 percent in several case series [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/15-22\" class=\"abstract_t\">15-22</a>]. Polysensitization is common; a multicenter study of 423 patients found an average of four positive patch tests per patient [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/15\" class=\"abstract_t\">15</a>]. The number of sensitivities appears to increase with the disease duration [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/15\" class=\"abstract_t\">15</a>].</p><p>The increased susceptibility to contact dermatitis in patients with stasis dermatitis and leg ulcers may be due to several factors, including [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/23-25\" class=\"abstract_t\">23-25</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Prolonged and repeated contact with topical preparations containing strong sensitizers </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Local hypervascularization</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased number of lymphocytes and Langerhans cells in the affected skin </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Impairment of the skin barrier function</p><p/><p>The substances most frequently responsible for contact sensitization among patients with stasis dermatitis <span class=\"nowrap\">and/or</span> leg ulcers are ingredients of many emollients and topical prescription or over-the-counter preparations, including [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/15-17,26-29\" class=\"abstract_t\">15-17,26-29</a>]: </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Myroxylon pereirae (formerly called Balsam of Peru) and fragrances</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=lanolin-drug-information\" class=\"drug drug_general\">Lanolin</a> (wool alcohol or Amerchol L101) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Rubber and constituents of rubber, rubber accelerators, and latex products </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bandages, dressings, or adhesives (eg, colophony, epoxy resin, and formaldehyde resin). Modern hydrocolloid dressings are generally well tolerated. However, reactions to hydrocolloid gels have been reported and may be due to pentaerythritol ester of hydrogenated rosin, a tackifying agent that commonly cross-reacts with colophony [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/27,30\" class=\"abstract_t\">27,30</a>]. </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Topical antibiotics (eg, <a href=\"topic.htm?path=neomycin-drug-information\" class=\"drug drug_general\">neomycin</a>, <a href=\"topic.htm?path=bacitracin-drug-information\" class=\"drug drug_general\">bacitracin</a>, and aminoglycosides) and antiseptics (eg, povidone-iodine, benzalkonium chloride, <a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">chlorhexidine</a>, and clioquinol) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Topical corticosteroids. A list of cross-reacting topical corticosteroids is provided in a figure (<a href=\"image.htm?imageKey=DERM%2F63402\" class=\"graphic graphic_figure graphicRef63402 \">figure 1</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>(See <a href=\"topic.htm?path=common-allergens-in-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Common allergens in allergic contact dermatitis&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H59262247\"><span class=\"h2\">Autosensitization</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Autosensitization (autoeczematization or &quot;id&quot; reaction) refers to an acute, pruritic papulovesicular eruption that develops at cutaneous sites distant from a primary focus and is unrelated to the inciting cause of the primary inflammation [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/31\" class=\"abstract_t\">31</a>]. Autosensitization has been reported in association with stasis dermatitis, contact dermatitis, and bacterial or fungal infections [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/32,33\" class=\"abstract_t\">32,33</a>]. Typically, the autoeczematization develops one to two weeks after the primary inflammation and most frequently involves the forearms, thighs, trunk, and face [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/34\" class=\"abstract_t\">34</a>].</p><p>The pathogenesis is not fully understood. One hypothesis is that autoeczematization is due to hyperirritability of the skin induced by immunologic or nonimmunologic stimuli and mediated by epidermal cytokines. Histologic findings are nonspecific and include spongiosis and a dermal lymphohistiocytic infiltrate with eosinophils. </p><p class=\"headingAnchor\" id=\"H523344193\"><span class=\"h2\">Superinfection</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with acute stasis dermatitis, moist, exudative lesions are often extensively colonized by bacteria and fungi. The disruption of the epidermal barrier integrity by inflammation or scratching favors the secondary infection of eczematous lesions. <em>Staphylococcus aureus</em> and <em>S. pyogenes </em>are the most frequent cause of superficial (impetiginization) or deep (cellulitis and erysipelas) superinfection of stasis dermatitis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/14\" class=\"abstract_t\">14</a>]. (See <a href=\"topic.htm?path=impetigo\" class=\"medical medical_review\">&quot;Impetigo&quot;</a> and <a href=\"topic.htm?path=cellulitis-and-skin-abscess-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Cellulitis and skin abscess: Clinical manifestations and diagnosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H26659798\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnosis of stasis dermatitis is usually clinical, based upon the clinical appearance of the skin lesions, ranging from erythema, scaling, and hyperpigmentation to edema, erosions, and crusts (<a href=\"image.htm?imageKey=DERM%2F70596%7EDERM%2F50640%7EPC%2F56758\" class=\"graphic graphic_picture graphicRef70596 graphicRef50640 graphicRef56758 \">picture 1A-B, 1E</a>); history of venous insufficiency; and other clinical signs of chronic venous insufficiency, including varicosities, pitting edema, and hyperpigmentation. </p><p>In patients in whom the diagnosis of stasis dermatitis is uncertain or who have atypical features (eg, solitary lesion or lack of ankle involvement), biopsy and histopathologic examination may confirm the diagnosis <span class=\"nowrap\">and/or</span> exclude other skin diseases such as allergic contact dermatitis, asteatotic eczema, or cutaneous malignancies (particularly in patients with a solitary lesion) [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/35\" class=\"abstract_t\">35</a>]. (See <a href=\"#H311755\" class=\"local\">'Pathology'</a> above.)</p><p>Patch testing is often necessary to determine if a secondary allergic contact dermatitis is present. (See <a href=\"#H108539\" class=\"local\">'Differential diagnosis'</a> below and <a href=\"#H59263447\" class=\"local\">'Patch testing'</a> below.)</p><p>Color Doppler assessment of the blood flow in the lower limbs is helpful in evaluating venous incompetence <span class=\"nowrap\">and/or</span> diagnosing deep venous thrombosis in patients with skin findings but without obvious manifestations of venous insufficiency. Arterial study may be necessary to evaluate arterial disease in patients with trophic changes (eg, atrophie blanche or ulcerations). (See <a href=\"topic.htm?path=diagnostic-evaluation-of-lower-extremity-chronic-venous-insufficiency#H3\" class=\"medical medical_review\">&quot;Diagnostic evaluation of lower extremity chronic venous insufficiency&quot;, section on 'Duplex ultrasonography'</a>.)</p><p class=\"headingAnchor\" id=\"H106493086\"><span class=\"h1\">ADDITIONAL EVALUATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Laboratory tests are not usually necessary for the diagnosis of stasis dermatitis. However, laboratory evaluation may be indicated in the assessment of chronic venous insufficiency, particularly prior to intervention (eg, vein ablation procedure) [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/36\" class=\"abstract_t\">36</a>]. </p><p>Bacterial cultures <span class=\"nowrap\">and/or</span> mycologic studies (eg, potassium hydroxide [KOH] preparation) are useful when bacterial or fungal superinfection or primary tinea corporis are suspected.</p><p class=\"headingAnchor\" id=\"H59263447\"><span class=\"h2\">Patch testing</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patch testing for contact sensitization may be warranted for patients who experience a worsening of symptoms despite appropriate skin care and topical therapy. Standard series of allergens should be used, in addition to other series selected on the basis of exposure history and clinical suspicion (eg, corticosteroids, rubber, preservative, excipients, antioxidants, fragrance, textiles, and topical medicines or products used by the patient). (See <a href=\"topic.htm?path=patch-testing\" class=\"medical medical_review\">&quot;Patch testing&quot;</a> and <a href=\"topic.htm?path=common-allergens-in-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Common allergens in allergic contact dermatitis&quot;</a>.)</p><p>The specific standard series may vary depending upon the location of the patch testing center [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/37\" class=\"abstract_t\">37</a>]. Descriptions of the test substances included in the most common standard series are available through DermNet NZ (<a href=\"http://www.dermnetnz.org/dermatitis/standard-patch.html&amp;token=DZBFcEpmYKftqlb205F0ezrdg0eDzNpKCgIwSAFr7y9WRNax/Ev/9ALJ1DT7rhR8AMHzX4RqIq7Eo1Z0rAFeQQ==&amp;TOPIC_ID=13670\" target=\"_blank\" class=\"external\">www.dermnetnz.org/dermatitis/standard-patch.html</a>).</p><p class=\"headingAnchor\" id=\"H108539\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Skin disorders that may mimic stasis dermatitis include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Irritant or allergic contact dermatitis (<a href=\"image.htm?imageKey=DERM%2F51220\" class=\"graphic graphic_picture graphicRef51220 \">picture 4</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Asteatotic eczema (eczema craquel&eacute;) (<a href=\"image.htm?imageKey=DERM%2F63945\" class=\"graphic graphic_picture graphicRef63945 \">picture 5</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lichen simplex chronicus (<a href=\"image.htm?imageKey=DERM%2F73843\" class=\"graphic graphic_picture graphicRef73843 \">picture 6</a>) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Psoriasis (<a href=\"image.htm?imageKey=DERM%2F77308\" class=\"graphic graphic_picture graphicRef77308 \">picture 7</a>) (see <a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis#H10\" class=\"medical medical_review\">&quot;Epidemiology, clinical manifestations, and diagnosis of psoriasis&quot;, section on 'Chronic plaque psoriasis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dermatophyte infection (tinea corporis) (<a href=\"image.htm?imageKey=DERM%2F53823\" class=\"graphic graphic_picture graphicRef53823 \">picture 8</a>), which may also be a complication of stasis dermatitis (see <a href=\"#H523344193\" class=\"local\">'Superinfection'</a> above and <a href=\"topic.htm?path=dermatophyte-tinea-infections#H23\" class=\"medical medical_review\">&quot;Dermatophyte (tinea) infections&quot;, section on 'Tinea corporis'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lower limb cellulitis, which may also be a complication of stasis dermatitis (see <a href=\"topic.htm?path=cellulitis-and-skin-abscess-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Cellulitis and skin abscess: Clinical manifestations and diagnosis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Actinically damaged skin (multiple actinic keratoses) (see <a href=\"topic.htm?path=epidemiology-natural-history-and-diagnosis-of-actinic-keratosis\" class=\"medical medical_review\">&quot;Epidemiology, natural history, and diagnosis of actinic keratosis&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypertrophic lichen planus (<a href=\"image.htm?imageKey=DERM%2F54396%7EDERM%2F81589\" class=\"graphic graphic_picture graphicRef54396 graphicRef81589 \">picture 9A-B</a>) (see <a href=\"topic.htm?path=lichen-planus#H6\" class=\"medical medical_review\">&quot;Lichen planus&quot;, section on 'Clinical features'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Necrobiosis lipoidica (<a href=\"image.htm?imageKey=DERM%2F50781%7EDERM%2F63574\" class=\"graphic graphic_picture graphicRef50781 graphicRef63574 \">picture 10A-B</a>) (see <a href=\"topic.htm?path=necrobiosis-lipoidica\" class=\"medical medical_review\">&quot;Necrobiosis lipoidica&quot;</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pretibial myxedema (<a href=\"image.htm?imageKey=DERM%2F64524\" class=\"graphic graphic_picture graphicRef64524 \">picture 11</a>) (see <a href=\"topic.htm?path=pretibial-myxedema-thyroid-dermopathy-in-autoimmune-thyroid-disease#H57417960\" class=\"medical medical_review\">&quot;Pretibial myxedema (thyroid dermopathy) in autoimmune thyroid disease&quot;, section on 'Clinical features'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Skin cancer (squamous cell carcinoma, basal cell carcinoma) (see <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-cutaneous-squamous-cell-carcinoma-scc\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)&quot;</a> and <a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-features-of-basal-cell-carcinoma#H21\" class=\"medical medical_review\">&quot;Epidemiology, pathogenesis, and clinical features of basal cell carcinoma&quot;, section on 'Clinical presentation'</a>) </p><p/><p class=\"headingAnchor\" id=\"H26659847\"><span class=\"h1\">MANAGEMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management of the patient with stasis eczema involves the treatment of the underlying chronic venous insufficiency, symptomatic treatment of skin dryness, pruritus, inflammation, and prevention of ulceration.</p><p class=\"headingAnchor\" id=\"H1081671955\"><span class=\"h2\">Treatment of underlying chronic venous insufficiency</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Treatment of the underlying venous hypertension is the mainstay of treatment of stasis dermatitis. It may involve:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>General measures to reduce edema and venous hypertension (eg, leg elevation, daily walking, exercise, weight reduction) (see <a href=\"topic.htm?path=medical-management-of-lower-extremity-chronic-venous-disease#H3\" class=\"medical medical_review\">&quot;Medical management of lower extremity chronic venous disease&quot;, section on 'General measures'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Continuous compression therapy (see <a href=\"topic.htm?path=medical-management-of-lower-extremity-chronic-venous-disease#H6\" class=\"medical medical_review\">&quot;Medical management of lower extremity chronic venous disease&quot;, section on 'Compression therapy'</a> and <a href=\"topic.htm?path=compression-therapy-for-the-treatment-of-chronic-venous-insufficiency\" class=\"medical medical_review\">&quot;Compression therapy for the treatment of chronic venous insufficiency&quot;</a> and <a href=\"topic.htm?path=compression-therapy-for-the-treatment-of-chronic-venous-insufficiency#H68314433\" class=\"medical medical_review\">&quot;Compression therapy for the treatment of chronic venous insufficiency&quot;, section on 'Static compression therapy'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Systemic therapy, including venoactive or phlebotonic drugs (eg, hydroxyethylrutoside, escin [horse chestnut extract], calcium dobesilate), flavonoids (eg, diosmin and hesperidin, diosmiplex), or <a href=\"topic.htm?path=pentoxifylline-drug-information\" class=\"drug drug_general\">pentoxifylline</a> [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/38-40\" class=\"abstract_t\">38-40</a>] (see <a href=\"topic.htm?path=medical-management-of-lower-extremity-chronic-venous-disease#H13\" class=\"medical medical_review\">&quot;Medical management of lower extremity chronic venous disease&quot;, section on 'Pharmacologic therapy'</a>)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Surgical therapy (see <a href=\"topic.htm?path=open-surgical-techniques-for-lower-extremity-vein-ablation\" class=\"medical medical_review\">&quot;Open surgical techniques for lower extremity vein ablation&quot;</a> and <a href=\"topic.htm?path=endovenous-laser-ablation-for-the-treatment-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">&quot;Endovenous laser ablation for the treatment of lower extremity chronic venous disease&quot;</a> and <a href=\"topic.htm?path=radiofrequency-ablation-for-the-treatment-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">&quot;Radiofrequency ablation for the treatment of lower extremity chronic venous disease&quot;</a>)</p><p/><p>In a series of 10 patients with stasis&nbsp;dermatitis&nbsp;of the lower leg and great saphenous vein incompetence, healing of dermatitis occurred in 8 to 12 weeks following flush ligation and saphenectomy [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/5\" class=\"abstract_t\">5</a>]. No recurrence was noted at one year. </p><p class=\"headingAnchor\" id=\"H1081672000\"><span class=\"h2\">Skin care</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Gentle skin cleansing and frequent use of bland emollients are indicated for the symptomatic treatment of skin dryness and pruritus associated with stasis dermatitis. Patients should gently wash their legs daily using mild non-soap (synthetic) liquid cleansers (eg, Dove, Olay, Cetaphil, Aveeno, Neutrogena) to remove scale, bacteria, and crusts. Products without common preservative allergens or fragrance are less irritating and less likely to induce contact sensitization.</p><p>Emollients provide a film of oil to lubricate the skin, which limits dryness and itching. Petrolatum-based products are preferred to emollients containing <a href=\"topic.htm?path=lanolin-drug-information\" class=\"drug drug_general\">lanolin</a> or fragrances to reduce the risk of contact sensitization. White petroleum jelly is effective, inexpensive, and non-sensitizing. Emollients can be applied multiple times per day. Emollients are best applied when the skin is damp (ie, immediately after showering or bathing) and may be applied after wet dressings to seal in hydration.</p><p class=\"headingAnchor\" id=\"H59483562\"><span class=\"h2\">Patients with acute stasis dermatitis</span></p><p class=\"headingAnchor\" id=\"H312177\"><span class=\"h3\">Topical corticosteroids</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest topical corticosteroids for patients with stasis dermatitis who have erythema, pruritus, vesiculation, and oozing. High- or mid-potency corticosteroids (group III and IV) (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 3</a>) in an ointment formulation can be applied to the affected skin once or twice daily for one to two weeks. A prolonged use of high-potency corticosteroids should be avoided, since they may induce skin atrophy and increase the risk of ulceration.</p><p>Corticosteroid preparations containing emulsifiers and additives should be avoided to minimize the risk of sensitization; petrolatum-based topical corticosteroids (eg, <a href=\"topic.htm?path=triamcinolone-drug-information\" class=\"drug drug_general\">triamcinolone</a> ointment, <a href=\"topic.htm?path=fluocinolone-drug-information\" class=\"drug drug_general\">fluocinolone</a> ointment) are preferred because they do not contain any additives. Nonetheless, contact sensitization to topical corticosteroids may occur; a list of cross-reacting topical corticosteroids is provided in a figure (<a href=\"image.htm?imageKey=DERM%2F63402\" class=\"graphic graphic_figure graphicRef63402 \">figure 1</a>). </p><p>There are few low-quality studies evaluating topical corticosteroids for the treatment of stasis dermatitis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/29,41\" class=\"abstract_t\">29,41</a>]. In a small trial, patients treated with <a href=\"topic.htm?path=betamethasone-drug-information\" class=\"drug drug_general\">betamethasone</a> valerate foam 0.12% or placebo twice daily for 28 days had similar improvement of edema, postinflammatory hyperpigmentation, or pruritus [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/29\" class=\"abstract_t\">29</a>]. However, patients in the betamethasone group had greater improvement compared with baseline than those in the placebo group. Whether stronger potency corticosteroids or an ointment preparation rather than foam would be more beneficial is not known.</p><p class=\"headingAnchor\" id=\"H26659861\"><span class=\"h3\">Wet dressings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients with exudative eczema, wet dressings may facilitate the removal of crusts and exudate and reduce pruritus. Wet dressings are applied using tap water, saline, or an appropriate anti-infective solution diluted from stock&nbsp;(eg, zinc and copper sulfate solution; acetic acid; potassium permanganate; or <a href=\"topic.htm?path=aluminum-acetate-drug-information\" class=\"drug drug_general\">aluminum acetate</a> [Burow's solution] or subacetate). </p><p>Saturated, but not dripping, soft cotton dermatologic roll gauze or cloths are applied directly to affected areas and covered with dry cotton that is light and air permeable.&nbsp;The wet dressing is left in place for two to three hours and may be applied two to three times daily or continuously in more severe cases and motivated patients.&nbsp;Emollients may be applied after removal to moisturize and seal in attained hydration.</p><p>Wet dressings may be used in conjunction with topical corticosteroids. The addition of dermatologic wet dressings to topical corticosteroids may increase the penetration and absorption of the corticosteroids.</p><p>In patients with bacterial superinfection, antibacterial wet dressings may help clear secondary impetiginization and obviate the need for topical or oral antibiotic therapy. </p><p class=\"headingAnchor\" id=\"H26659868\"><span class=\"h3\">Closed topical dressings</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The <a href=\"topic.htm?path=zinc-gelatin-drug-information\" class=\"drug drug_general\">Unna boot</a> is a closed topical dressing consisting of a moist zinc oxide-impregnated bandage that provides nonelastic compression and topical treatment. Unna boots may be of benefit in decreasing cutaneous inflammation, improving hydration, decreasing pruritus, improving impetiginized eczema, and preventing manipulation, particularly when venous ulcers are present [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/42\" class=\"abstract_t\">42</a>]. (See <a href=\"topic.htm?path=compression-therapy-for-the-treatment-of-chronic-venous-insufficiency#H3733328637\" class=\"medical medical_review\">&quot;Compression therapy for the treatment of chronic venous insufficiency&quot;, section on 'Unna boot'</a>.)</p><p class=\"headingAnchor\" id=\"H59483569\"><span class=\"h2\">Patients with recalcitrant stasis dermatitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients in whom topical corticosteroids do not adequately relieve symptoms of inflammation or who experience a worsening of symptoms despite appropriate skin care and topical therapy may have a secondary allergic contact dermatitis <span class=\"nowrap\">and/or</span> autosensitization (see <a href=\"#H310424\" class=\"local\">'Complications'</a> above). For these patients, a short course of systemic corticosteroids (eg, <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> 20 to 30 mg daily for five to seven days) may be indicated. An alternative is a single dose of intramuscular <a href=\"topic.htm?path=triamcinolone-drug-information\" class=\"drug drug_general\">triamcinolone</a> (40 mg). </p><p>Data on the efficacy of systemic corticosteroids for the treatment of recalcitrant stasis dermatitis are lacking. Their use is based upon indirect evidence of efficacy in severe allergic contact dermatitis and clinical experience. (See <a href=\"topic.htm?path=management-of-allergic-contact-dermatitis\" class=\"medical medical_review\">&quot;Management of allergic contact dermatitis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H523344201\"><span class=\"h2\">Treatment of superinfection</span></p><p class=\"headingAnchor\" id=\"H26659882\"><span class=\"h3\">Impetiginized lesions</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest topical antibiotic therapy for patients with stasis dermatitis and impetiginized lesions. Topical antibacterial ointments should be selected based upon the results of bacterial culture, if available, and risk of contact sensitization. <a href=\"topic.htm?path=mupirocin-drug-information\" class=\"drug drug_general\">Mupirocin</a> is the topical antibiotic of choice because it is unlikely to cause cutaneous sensitization [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/43,44\" class=\"abstract_t\">43,44</a>]. Topical <a href=\"topic.htm?path=erythromycin-drug-information\" class=\"drug drug_general\">erythromycin</a> ointment is an alternative treatment when mupirocin is not tolerated [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=impetigo#H1110810\" class=\"medical medical_review\">&quot;Impetigo&quot;, section on 'Topical therapy'</a>.)</p><p>Contact sensitivity to <a href=\"topic.htm?path=bacitracin-drug-information\" class=\"drug drug_general\">bacitracin</a>, <a href=\"topic.htm?path=neomycin-drug-information\" class=\"drug drug_general\">neomycin</a>, and aminoglycosides is frequently seen in patch tested patients with stasis dermatitis or contact dermatitis and these agents should be avoided. Triclosan-based topical antimicrobial preparations are an infrequent cause of contact sensitization and may be used as an alternative to topical antibiotics [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/46\" class=\"abstract_t\">46</a>]. Direct <a href=\"topic.htm?path=chlorhexidine-gluconate-drug-information\" class=\"drug drug_general\">chlorhexidine</a> scrubs in the shower or dilute bleach baths (one half cup in a bathtub half full of tepid water) are also useful to decrease the cutaneous bacterial load.</p><p class=\"headingAnchor\" id=\"H523344235\"><span class=\"h3\">Secondary cellulitis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For patients with more extensive infection and signs of cellulitis or other soft tissue infection we suggest systemic antibiotics. Pending culture results, empiric therapy options for group B <em>Streptococcus, </em>methicillin-resistant <em>Staphylococcus aureus,</em> and other beta-hemolytic streptococci include oral <a href=\"topic.htm?path=clindamycin-drug-information\" class=\"drug drug_general\">clindamycin</a>, <a href=\"topic.htm?path=trimethoprim-sulfamethoxazole-co-trimoxazole-drug-information\" class=\"drug drug_general\">trimethoprim-sulfamethoxazole</a>, tetracyclines, and <a href=\"topic.htm?path=linezolid-drug-information\" class=\"drug drug_general\">linezolid</a>. (See <a href=\"topic.htm?path=cellulitis-and-skin-abscess-in-adults-treatment\" class=\"medical medical_review\">&quot;Cellulitis and skin abscess in adults: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H140906706\"><span class=\"h2\">Treatment of lipodermatosclerosis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Compression therapy is widely accepted as first-line treatment for patients with chronic dermatosclerosis [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/47\" class=\"abstract_t\">47</a>]. Compression therapy and pharmacologic therapy for patients with lipodermatosclerosis are discussed in detail separately. (See <a href=\"topic.htm?path=medical-management-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">&quot;Medical management of lower extremity chronic venous disease&quot;</a>.) </p><p class=\"headingAnchor\" id=\"H140906045\"><span class=\"h2\">Prevention of venous ulcers</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with stasis dermatitis should be educated about the importance of lifestyle changes and specific interventions to prevent venous ulcers, including [<a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/48\" class=\"abstract_t\">48</a>]:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Using compression hosiery</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Undertaking a program of regular physical activity </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Losing weight </p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Avoiding local trauma</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Seeking early medical intervention if skin damage is noticed </p><p/><p class=\"headingAnchor\" id=\"H523344250\"><span class=\"h1\">TREATMENT OF ULCERS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The management of ulcers in patients with stasis dermatitis is discussed separately. (See <a href=\"topic.htm?path=medical-management-of-lower-extremity-chronic-venous-disease#H28\" class=\"medical medical_review\">&quot;Medical management of lower extremity chronic venous disease&quot;, section on 'Ulcer care'</a>.)</p><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=varicose-veins-and-other-vein-disease-in-the-legs-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Varicose veins and other vein disease in the legs (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H26659945\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Stasis dermatitis, or stasis eczema, is a common inflammatory dermatosis of the lower extremities that occurs in patients with chronic venous insufficiency, often in association with other signs of chronic venous disease such as varicose veins, dependent chronic edema, lipodermatosclerosis, and ulcerations. (See <a href=\"#H358752\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Signs and symptoms of stasis dermatitis include edema, inflammatory and trophic skin changes, pruritus, and hyperpigmentation. Manifestations of more advanced venous disease include lipodermatosclerosis (<a href=\"image.htm?imageKey=DERM%2F65447\" class=\"graphic graphic_picture graphicRef65447 \">picture 2</a>), lymphedema, and ulceration. (See <a href=\"#H310245\" class=\"local\">'Clinical presentation'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Contact sensitization is a common complication of stasis dermatitis. Contact sensitization should be suspected in patients with atypical presentations and in patients failing to respond to appropriate treatment for stasis dermatitis. The most common contact allergens include balsam of Peru, fragrances, <a href=\"topic.htm?path=lanolin-drug-information\" class=\"drug drug_general\">lanolin</a>, and topical antibiotics and antiseptics. (See <a href=\"#H107526\" class=\"local\">'Contact sensitization'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of stasis dermatitis is based upon the clinical appearance of the skin lesions (ranging from erythema, scaling, and hyperpigmentation to edema, erosions, and crusts) (<a href=\"image.htm?imageKey=DERM%2F70596%7EDERM%2F50640%7EPC%2F56758\" class=\"graphic graphic_picture graphicRef70596 graphicRef50640 graphicRef56758 \">picture 1A-B, 1E</a>); history of venous insufficiency; and other clinical signs of chronic venous insufficiency, including varicosities, pitting edema, and hyperpigmentation. In patients with atypical presentations or solitary lesions, biopsy and histopathologic examination may confirm the diagnosis <span class=\"nowrap\">and/or</span> exclude other dermatoses or skin cancer. (See <a href=\"#H26659798\" class=\"local\">'Diagnosis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Treatment of the underlying venous insufficiency is the mainstay of therapy for stasis dermatitis. Treatment of venous insufficiency is discussed separately. (See <a href=\"topic.htm?path=overview-and-management-of-lower-extremity-chronic-venous-disease#H26\" class=\"medical medical_review\">&quot;Overview and management of lower extremity chronic venous disease&quot;, section on 'Summary and recommendations'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gentle skin cleansing and emollients are the initial treatment for skin dryness and pruritus in patients with stasis dermatitis. Petrolatum-based emollients are preferred to preparations containing <a href=\"topic.htm?path=lanolin-drug-information\" class=\"drug drug_general\">lanolin</a> or fragrances to avoid contact sensitization. (See <a href=\"#H1081672000\" class=\"local\">'Skin care'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with acute stasis dermatitis who have erythema, pruritus, vesiculation, and oozing, we suggest topical corticosteroids (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). High- or mid-potency corticosteroids (group III and IV) (<a href=\"image.htm?imageKey=DERM%2F62402\" class=\"graphic graphic_table graphicRef62402 \">table 3</a>) in an ointment formulation may be applied once or twice daily for one to two weeks to the affected skin. Wet dressings may be used in conjunction with topical corticosteroids in patients with exudative eczema and crusting. (See <a href=\"#H59483562\" class=\"local\">'Patients with acute stasis dermatitis'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients in whom topical corticosteroids do not adequately relieve symptoms of inflammation or who have secondary allergic contact dermatitis, a short course of systemic corticosteroids (eg, <a href=\"topic.htm?path=prednisone-drug-information\" class=\"drug drug_general\">prednisone</a> 20 to 30 mg daily for five to seven days) may be indicated. (See <a href=\"#H59483569\" class=\"local\">'Patients with recalcitrant stasis dermatitis'</a> above.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/1\" class=\"nounderline abstract_t\">Deguchi E, Imafuku S, Nakayama J. Ulcerating stasis dermatitis of the forearm due to arteriovenous fistula: a case report and review of the published work. J Dermatol 2010; 37:550.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/2\" class=\"nounderline abstract_t\">Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epidemiology of chronic venous insufficiency and varicose veins. Ann Epidemiol 2005; 15:175.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/3\" class=\"nounderline abstract_t\">Yal&ccedil;in B, Tamer E, Toy GG, et al. The prevalence of skin diseases in the elderly: analysis of 4099 geriatric patients. Int J Dermatol 2006; 45:672.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/4\" class=\"nounderline abstract_t\">Fiebig A, Krusche P, Wolf A, et al. Heritability of chronic venous disease. Hum Genet 2010; 127:669.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/5\" class=\"nounderline abstract_t\">Sippel K, Mayer D, Ballmer B, et al. Evidence that venous hypertension causes stasis dermatitis. Phlebology 2011; 26:361.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/6\" class=\"nounderline abstract_t\">Bergan JJ, Schmid-Sch&ouml;nbein GW, Smith PD, et al. Chronic venous disease. N Engl J Med 2006; 355:488.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/7\" class=\"nounderline abstract_t\">Gosnell AL, Nedorost ST. Stasis dermatitis as a complication of amlodipine therapy. J Drugs Dermatol 2009; 8:135.</a></li><li class=\"breakAll\">Stasis dermatitis. In: Weedon's Skin Pathology, Third edition, Weedon D (Ed), Churchill Livingstone Elsevier, 2010.</li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/9\" class=\"nounderline abstract_t\">Northcutt AD, Tschen JA. The routine use of iron stain for biopsies of dermatoses of the legs. J Cutan Pathol 2015; 42:717.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/10\" class=\"nounderline abstract_t\">Pappas PJ, DeFouw DO, Venezio LM, et al. Morphometric assessment of the dermal microcirculation in patients with chronic venous insufficiency. J Vasc Surg 1997; 26:784.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/11\" class=\"nounderline abstract_t\">Walsh SN, Santa Cruz DJ. Lipodermatosclerosis: a clinicopathological study of 25 cases. J Am Acad Dermatol 2010; 62:1005.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/12\" class=\"nounderline abstract_t\">Huang TM, Lee JY. Lipodermatosclerosis: a clinicopathologic study of 17 cases and differential diagnosis from erythema nodosum. J Cutan Pathol 2009; 36:453.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/13\" class=\"nounderline abstract_t\">Ekl&ouml;f B, Rutherford RB, Bergan JJ, et al. Revision of the CEAP classification for chronic venous disorders: consensus statement. J Vasc Surg 2004; 40:1248.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/14\" class=\"nounderline abstract_t\">Hirschmann JV, Raugi GJ. Lower limb cellulitis and its mimics: part II. Conditions that simulate lower limb cellulitis. J Am Acad Dermatol 2012; 67:177.e1.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/15\" class=\"nounderline abstract_t\">Barbaud A, Collet E, Le Coz CJ, et al. Contact allergy in chronic leg ulcers: results of a multicentre study carried out in 423 patients and proposal for an updated series of patch tests. Contact Dermatitis 2009; 60:279.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/16\" class=\"nounderline abstract_t\">Machet L, Couh&eacute; C, Perrinaud A, et al. A high prevalence of sensitization still persists in leg ulcer patients: a retrospective series of 106 patients tested between 2001 and 2002 and a meta-analysis of 1975-2003 data. Br J Dermatol 2004; 150:929.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/17\" class=\"nounderline abstract_t\">Tavadia S, Bianchi J, Dawe RS, et al. Allergic contact dermatitis in venous leg ulcer patients. Contact Dermatitis 2003; 48:261.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/18\" class=\"nounderline abstract_t\">Smart V, Alavi A, Coutts P, et al. Contact allergens in persons with leg ulcers: a Canadian study in contact sensitization. Int J Low Extrem Wounds 2008; 7:120.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/19\" class=\"nounderline abstract_t\">Janki&#263;evi&#263; J, Vesi&#263; S, Vuki&#263;evi&#263; J, et al. Contact sensitivity in patients with venous leg ulcers in Serbia: comparison with contact dermatitis patients and relationship to ulcer duration. Contact Dermatitis 2008; 58:32.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/20\" class=\"nounderline abstract_t\">Lim KS, Tang MB, Goon AT, Leow YH. Contact sensitization in patients with chronic venous leg ulcers in Singapore. Contact Dermatitis 2007; 56:94.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/21\" class=\"nounderline abstract_t\">Reichert-P&eacute;n&eacute;trat S, Barbaud A, Weber M, Schmutz JL. [Leg ulcers. Allergologic studies of 359 cases]. Ann Dermatol Venereol 1999; 126:131.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/22\" class=\"nounderline abstract_t\">Ebner H, Lindemayr H. [Leg ulcer and allergic eczematous contact dermatitis incidence of contact allergies induced by topical therapy (author's transl)]. Wien Klin Wochenschr 1977; 89:185.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/23\" class=\"nounderline abstract_t\">Bahmer FA, Lesch H. Density of Langerhans' cells in ATPase stained epidermal sheet preparations from stasis dermatitis skin of the lower leg. Acta Derm Venereol 1987; 67:301.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/24\" class=\"nounderline abstract_t\">Scott HJ, Coleridge Smith PD, Scurr JH. Histological study of white blood cells and their association with lipodermatosclerosis and venous ulceration. Br J Surg 1991; 78:210.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/25\" class=\"nounderline abstract_t\">Prakash AV, Davis MD. Contact dermatitis in older adults: a review of the literature. Am J Clin Dermatol 2010; 11:373.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/26\" class=\"nounderline abstract_t\">Gooptu C, Powell SM. The problems of rubber hypersensitivity (Types I and IV) in chronic leg ulcer and stasis eczema patients. Contact Dermatitis 1999; 41:89.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/27\" class=\"nounderline abstract_t\">Sasseville D, Tennstedt D, Lachapelle JM. Allergic contact dermatitis from hydrocolloid dressings. Am J Contact Dermat 1997; 8:236.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/28\" class=\"nounderline abstract_t\">Chang HY, Wong KM, Bosenberg M, et al. Myelogenous leukemia cutis resembling stasis dermatitis. J Am Acad Dermatol 2003; 49:128.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/29\" class=\"nounderline abstract_t\">Weiss SC, Nguyen J, Chon S, Kimball AB. A randomized controlled clinical trial assessing the effect of betamethasone valerate 0.12% foam on the short-term treatment of stasis dermatitis. J Drugs Dermatol 2005; 4:339.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/30\" class=\"nounderline abstract_t\">Renner R, Simon JC, Treudler R. Contact sensitization to modern wound dressings in 70 patients with chronic leg ulcers. Dermatitis 2013; 24:60.</a></li><li class=\"breakAll\">Belsito DV. Autosensitization dermatitis. In: Fitzpatrick's Dermatology in General Medicine, Seventh, Wolff K, Goldsmith Lowell A, Katz SI, Gilchrest BA, Paller AS (Eds), McGraw Hill Medical, New York, NY 2008. Vol I, p.167.</li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/32\" class=\"nounderline abstract_t\">Bendl BJ. Nummular eczema of statis origin. The backbone of a morphologic pattern of diverse etiology. Int J Dermatol 1979; 18:129.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/33\" class=\"nounderline abstract_t\">HAXTHAUSEN H. Generalized ids autosensitization in varicose eczemas. Acta Derm Venereol 1955; 35:271.</a></li><li class=\"breakAll\">Belsito DV. Autosensitization dermatitis. In: Fitzpatrick's Dermatology in General Medicine, Seventh edition, Wolff K, Goldsmith LA, Katz SI, Gilchrest BA (Eds), McGraw Hill Medical, New York, NY 2008. Vol I, p.167.</li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/35\" class=\"nounderline abstract_t\">Weaver J, Billings SD. Initial presentation of stasis dermatitis mimicking solitary lesions: a previously unrecognized clinical scenario. J Am Acad Dermatol 2009; 61:1028.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/36\" class=\"nounderline abstract_t\">Gloviczki P, Comerota AJ, Dalsing MC, et al. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg 2011; 53:2S.</a></li><li class=\"breakAll\">http://dermnetnz.org/dermatitis/standard-patch.html (Accessed on July 27, 2011).</li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/38\" class=\"nounderline abstract_t\">Rabe E, Guex JJ, Morrison N, et al. Treatment of chronic venous disease with flavonoids: recommendations for treatment and further studies. Phlebology 2013; 28:308.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/39\" class=\"nounderline abstract_t\">Pittler MH, Ernst E. Horse chestnut seed extract for chronic venous insufficiency. Cochrane Database Syst Rev 2012; 11:CD003230.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/40\" class=\"nounderline abstract_t\">Rabe E, Jaeger KA, Bulitta M, Pannier F. Calcium dobesilate in patients suffering from chronic venous insufficiency: a double-blind, placebo-controlled, clinical trial. Phlebology 2011; 26:162.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/41\" class=\"nounderline abstract_t\">Henry M, Hanks G, Whelan A. A randomized, double-blind therapeutic trial of 0.25% desoxymethasone and 0.1% hydrocortisone 17-butyrate in the treatment of varicose eczema. Curr Med Res Opin 1980; 6:502.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/42\" class=\"nounderline abstract_t\">Mirande LM, Landolfi JM, Pedemonte LH. [Multiple applications of closed permanent wet dressings. Their mode of action]. Med Cutan Ibero Lat Am 1981; 9:67.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/43\" class=\"nounderline abstract_t\">Tomljanovi&#263;-Veselski M, Lipozenci&#263; J, Lugovi&#263; L. Contact allergy to special and standard allergens in patients with venous ulcers. Coll Antropol 2007; 31:751.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/44\" class=\"nounderline abstract_t\">Jindal R, Sharma NL, Mahajan VK, Tegta GR. Contact sensitization in venous eczema: preliminary results of patch testing with Indian standard series and topical medicaments. Indian J Dermatol Venereol Leprol 2009; 75:136.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/45\" class=\"nounderline abstract_t\">Bernstein SC, Roenigk RK. Surgical pearl: erythromycin ointment for topical antibiotic wound care. J Am Acad Dermatol 1995; 32:659.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/46\" class=\"nounderline abstract_t\">Schena D, Papagrigoraki A, Girolomoni G. Sensitizing potential of triclosan and triclosan-based skin care products in patients with chronic eczema. Dermatol Ther 2008; 21 Suppl 2:S35.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/47\" class=\"nounderline abstract_t\">Miteva M, Romanelli P, Kirsner RS. Lipodermatosclerosis. Dermatol Ther 2010; 23:375.</a></li><li><a href=\"https://www.uptodate.com/contents/stasis-dermatitis/abstract/48\" class=\"nounderline abstract_t\">Brown A. Life-style advice and self-care strategies for venous leg ulcer patients: what is the evidence? J Wound Care 2012; 21:342.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 13670 Version 18.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H26659945\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H358752\" id=\"outline-link-H358752\">INTRODUCTION</a></li><li><a href=\"#H214055\" id=\"outline-link-H214055\">EPIDEMIOLOGY</a></li><li><a href=\"#H26659689\" id=\"outline-link-H26659689\">PATHOPHYSIOLOGY</a></li><li><a href=\"#H311755\" id=\"outline-link-H311755\">PATHOLOGY</a></li><li><a href=\"#H310245\" id=\"outline-link-H310245\">CLINICAL PRESENTATION</a></li><li><a href=\"#H310424\" id=\"outline-link-H310424\">COMPLICATIONS</a><ul><li><a href=\"#H107526\" id=\"outline-link-H107526\">Contact sensitization</a></li><li><a href=\"#H59262247\" id=\"outline-link-H59262247\">Autosensitization</a></li><li><a href=\"#H523344193\" id=\"outline-link-H523344193\">Superinfection</a></li></ul></li><li><a href=\"#H26659798\" id=\"outline-link-H26659798\">DIAGNOSIS</a></li><li><a href=\"#H106493086\" id=\"outline-link-H106493086\">ADDITIONAL EVALUATION</a><ul><li><a href=\"#H59263447\" id=\"outline-link-H59263447\">Patch testing</a></li></ul></li><li><a href=\"#H108539\" id=\"outline-link-H108539\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H26659847\" id=\"outline-link-H26659847\">MANAGEMENT</a><ul><li><a href=\"#H1081671955\" id=\"outline-link-H1081671955\">Treatment of underlying chronic venous insufficiency</a></li><li><a href=\"#H1081672000\" id=\"outline-link-H1081672000\">Skin care</a></li><li><a href=\"#H59483562\" id=\"outline-link-H59483562\">Patients with acute stasis dermatitis</a><ul><li><a href=\"#H312177\" id=\"outline-link-H312177\">- Topical corticosteroids</a></li><li><a href=\"#H26659861\" id=\"outline-link-H26659861\">- Wet dressings</a></li><li><a href=\"#H26659868\" id=\"outline-link-H26659868\">- Closed topical dressings</a></li></ul></li><li><a href=\"#H59483569\" id=\"outline-link-H59483569\">Patients with recalcitrant stasis dermatitis</a></li><li><a href=\"#H523344201\" id=\"outline-link-H523344201\">Treatment of superinfection</a><ul><li><a href=\"#H26659882\" id=\"outline-link-H26659882\">- Impetiginized lesions</a></li><li><a href=\"#H523344235\" id=\"outline-link-H523344235\">- Secondary cellulitis</a></li></ul></li><li><a href=\"#H140906706\" id=\"outline-link-H140906706\">Treatment of lipodermatosclerosis</a></li><li><a href=\"#H140906045\" id=\"outline-link-H140906045\">Prevention of venous ulcers</a></li></ul></li><li><a href=\"#H523344250\" id=\"outline-link-H523344250\">TREATMENT OF ULCERS</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H714779274\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H26659945\" id=\"outline-link-H26659945\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DERM/13670|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/63402\" class=\"graphic graphic_figure\">- Cross-reactivity of topical corticosteroids</a></li></ul></li><li><div id=\"DERM/13670|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/70596\" class=\"graphic graphic_picture\">- Stasis dermatitis early</a></li><li><a href=\"image.htm?imageKey=DERM/50640\" class=\"graphic graphic_picture\">- Stasis dermatitis advanced</a></li><li><a href=\"image.htm?imageKey=DERM/78163\" class=\"graphic graphic_picture\">- Stasis dermatitis advanced 2</a></li><li><a href=\"image.htm?imageKey=DERM/64878\" class=\"graphic graphic_picture\">- Advanced stasis dermatitis 4</a></li><li><a href=\"image.htm?imageKey=DERM/65447\" class=\"graphic graphic_picture\">- Lipodermatosclerosis 2</a></li><li><a href=\"image.htm?imageKey=DERM/87627\" class=\"graphic graphic_picture\">- Atrophie blanche lipodermatosclerosis 1</a></li><li><a href=\"image.htm?imageKey=PC/56758\" class=\"graphic graphic_picture\">- Skin changes of chronic venous insufficiency</a></li><li><a href=\"image.htm?imageKey=DERM/51220\" class=\"graphic graphic_picture\">- Contact dermatitis feet</a></li><li><a href=\"image.htm?imageKey=DERM/63945\" class=\"graphic graphic_picture\">- Asteatotic eczema</a></li><li><a href=\"image.htm?imageKey=DERM/73843\" class=\"graphic graphic_picture\">- Lichen simplex chronicus ankle</a></li><li><a href=\"image.htm?imageKey=DERM/77308\" class=\"graphic graphic_picture\">- Psoriasis legs</a></li><li><a href=\"image.htm?imageKey=DERM/53823\" class=\"graphic graphic_picture\">- Tinea corporis leg</a></li><li><a href=\"image.htm?imageKey=DERM/54396\" class=\"graphic graphic_picture\">- Hypertrophic lichen planus lesion</a></li><li><a href=\"image.htm?imageKey=DERM/81589\" class=\"graphic graphic_picture\">- Hypertrophic lichen planus2</a></li><li><a href=\"image.htm?imageKey=DERM/50781\" class=\"graphic graphic_picture\">- Necrobiosis lipoidica 2</a></li><li><a href=\"image.htm?imageKey=DERM/63574\" class=\"graphic graphic_picture\">- Necrobiosis lipoidica 3</a></li><li><a href=\"image.htm?imageKey=DERM/64524\" class=\"graphic graphic_picture\">- Pretibial myxedema II</a></li></ul></li><li><div id=\"DERM/13670|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DERM/98177\" class=\"graphic graphic_table\">- Drugs inducing edema</a></li><li><a href=\"image.htm?imageKey=SURG/52388\" class=\"graphic graphic_table\">- CEAP classification for chronic venous disorders</a></li><li><a href=\"image.htm?imageKey=DERM/62402\" class=\"graphic graphic_table\">- Topical corticosteroids</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=basic-mechanisms-and-pathophysiology-of-allergic-contact-dermatitis\" class=\"medical medical_review\">Basic mechanisms and pathophysiology of allergic contact dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cellulitis-and-skin-abscess-in-adults-treatment\" class=\"medical medical_review\">Cellulitis and skin abscess in adults: Treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cellulitis-and-skin-abscess-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Cellulitis and skin abscess: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=classification-of-lower-extremity-chronic-venous-disorders\" class=\"medical medical_review\">Classification of lower extremity chronic venous disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-cutaneous-squamous-cell-carcinoma-scc\" class=\"medical medical_review\">Clinical features and diagnosis of cutaneous squamous cell carcinoma (SCC)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">Clinical manifestations of lower extremity chronic venous disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=common-allergens-in-allergic-contact-dermatitis\" class=\"medical medical_review\">Common allergens in allergic contact dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=compression-therapy-for-the-treatment-of-chronic-venous-insufficiency\" class=\"medical medical_review\">Compression therapy for the treatment of chronic venous insufficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dermatophyte-tinea-infections\" class=\"medical medical_review\">Dermatophyte (tinea) infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-lower-extremity-chronic-venous-insufficiency\" class=\"medical medical_review\">Diagnostic evaluation of lower extremity chronic venous insufficiency</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=endovenous-laser-ablation-for-the-treatment-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">Endovenous laser ablation for the treatment of lower extremity chronic venous disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-clinical-manifestations-and-diagnosis-of-psoriasis\" class=\"medical medical_review\">Epidemiology, clinical manifestations, and diagnosis of psoriasis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-natural-history-and-diagnosis-of-actinic-keratosis\" class=\"medical medical_review\">Epidemiology, natural history, and diagnosis of actinic keratosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=epidemiology-pathogenesis-and-clinical-features-of-basal-cell-carcinoma\" class=\"medical medical_review\">Epidemiology, pathogenesis, and clinical features of basal cell carcinoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=impetigo\" class=\"medical medical_review\">Impetigo</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lichen-planus\" class=\"medical medical_review\">Lichen planus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-allergic-contact-dermatitis\" class=\"medical medical_review\">Management of allergic contact dermatitis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=medical-management-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">Medical management of lower extremity chronic venous disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=necrobiosis-lipoidica\" class=\"medical medical_review\">Necrobiosis lipoidica</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=open-surgical-techniques-for-lower-extremity-vein-ablation\" class=\"medical medical_review\">Open surgical techniques for lower extremity vein ablation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-and-management-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">Overview and management of lower extremity chronic venous disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=patch-testing\" class=\"medical medical_review\">Patch testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pathophysiology-of-chronic-venous-disease\" class=\"medical medical_review\">Pathophysiology of chronic venous disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=varicose-veins-and-other-vein-disease-in-the-legs-the-basics\" class=\"medical medical_basics\">Patient education: Varicose veins and other vein disease in the legs (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=post-thrombotic-postphlebitic-syndrome\" class=\"medical medical_review\">Post-thrombotic (postphlebitic) syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pretibial-myxedema-thyroid-dermopathy-in-autoimmune-thyroid-disease\" class=\"medical medical_review\">Pretibial myxedema (thyroid dermopathy) in autoimmune thyroid disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=radiofrequency-ablation-for-the-treatment-of-lower-extremity-chronic-venous-disease\" class=\"medical medical_review\">Radiofrequency ablation for the treatment of lower extremity chronic venous disease</a></li></ul></div></div>","javascript":null}